Reference
Tomonari T, et al. A case of complete response with rechallenge-lenvatinib plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma refractory to multiple molecular-targeted agent treatments. Clinical Journal of Gastroenterology 16: 438-443, No. 3, Jun 2023. Available from: URL: http://doi.org/10.1007/s12328-023-01777-y
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1961, 48 (2023). https://doi.org/10.1007/s40278-023-41305-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-41305-0